Standardization of a method to study angiogenesis in a mouse model

Area of Science:

• Angiogenesis research
• In vivo models
• Drug discovery

Background:

• Uncontrolled angiogenesis is linked to pathologies.
• Existing animal models for angiogenesis lack quantitative specificity.
• A need exists for reproducible methods to study angiogenesis factors and inhibitors.

Purpose of the Study:

• To standardize a quantitative, reproducible method for in vivo angiogenesis studies.
• To investigate the anti-angiogenic effects of thalidomide using the standardized method.

Main Methods:

• Implantation of standardized sponges in mice.
• Administration of thalidomide to experimental groups.
• Quantification of angiogenesis by measuring hemoglobin content in sponges and serum.
• Statistical analysis using the Mann-Whitney test.

Main Results:

• Sponge-induced angiogenesis, quantified by the serum-to-sponge hemoglobin ratio, proved to be a reliable in vivo model.
• Thalidomide significantly suppressed sponge-induced angiogenesis.
• The results validate the developed standardized method for angiogenesis research.

Conclusions:

• The developed sponge implantation method provides a quantitative and reproducible approach for in vivo angiogenesis studies.
• Thalidomide exhibits anti-angiogenic properties, effectively suppressed by this model.
• This standardized method is valuable for characterizing angiogenesis factors and inhibitors.